Neuropace Inc
Change company Symbol lookup
Select an option...
NPCE Neuropace Inc
CLM Cornerstone Strategic Value Fund
RCI Rogers Communications Inc
ADRA Adara Acquisition Corp
EVTC Evertec Inc
OPEN Opendoor Technologies Inc
XAIR Beyond Air Inc
SHEL Shell PLC
CXE MFS High Income Municipal Trust
CWGL Crimson Wine Group Ltd
Go

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

NeuroPace, Inc. is a commercial-stage medical device company. The Company is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s novel and differentiated RNS System is the brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company’s RNS System is a platform that delivers care for patients suffering from drug-resistant epilepsy and offers a personalized solution and outcomes to the patients suffering from other brain disorders. RNS System is a device that records brain activity data and clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is engaged in treating other brain disorders including depression, impulse control disorders, memory disorders, and post-traumatic stress.

Postmarket

Last Trade
Delayed
$5.37
Change Since Close

Change Since Close

Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.

0.02 (0.37%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$5.35
Day's Change
-0.60 (-10.08%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
6.00
Day's Low
4.94
Volume
(Average)
Volume:
29,005

10-day average volume:
27,236
29,005
Historical quotes & splits

Mastercard Inc. Stock Rises Thursday, Still Underperforms Market

5:05 pm ET June 23, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Mastercard Inc. MA inched 0.19% higher to $316.76 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.95% to 3,795.73 and the Dow Jones Industrial Average DJIA rising 0.64% to 30,677.36. Mastercard Inc. closed $83.16 short of its 52-week high ($399.92), which the company reached on February 2nd.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amazon.com Inc. AMZN rose 3.20% to $112.44, Visa Inc. Cl A V rose 1.45% to $196.64, and American Express Co. AXP fell 1.90% to $141.65. Trading volume (2.4 M) remained 1.0 million below its 50-day average volume of 3.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled June 23, 2022.

(END) Dow Jones Newswires

June 23, 2022 17:05 ET (21:05 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.

3rd Party Research Disclosure